IDO1 and cancer: MSUCN nanocarriers that combine immunotherapy and photodynamic therapy, enabling synergistic anti-cancer therapy by actively targeting tumor cells with folic acid and stimulating the immune response by generating reactive oxygen species and inhibiting the IDO pathway.